logo

For the Inventor, By the Inventor

New York, NY, United States of America

Encysive Pharmaceuticals, Inc.


USPTO Granted Patents = 9

% Expired Patents = 77.8



Forward Citations = 94

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Chengde Wu (7 out of 31 patents)

silverMedal Wen Li (4 out of 43 patents)

bronzeMedal Robert V Market (4 out of 17 patents)

4.  Daxin Gao (4 out of 5 patents)

5.  George W Holland (4 out of 50 patents)

6.  Jamal M Kassir (3 out of 8 patents)

7.  Ronald J Biediger (3 out of 25 patents)

8.  Brian Dupre (2 out of 7 patents)

9.  Qi Chen (2 out of 3 patents)

10.  E Radford Decker (2 out of 3 patents)

11.  Jian Li (2 out of 2 patents)

12.  Ian Leslie Scott (2 out of 15 patents)

13.  Jie Chen (1 out of 52 patents)

14.  Eric Anderson (1 out of 47 patents)

15.  Adam Kois (1 out of 21 patents)


9 patents:

1. 7812038 - Carboxylic acid derivatives that inhibit the binding of integrins to their receptors (2010-10-12),
2. 7754892 - Processes for the preparation of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide (2010-07-13),
3. 7320989 - Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists (2008-01-22),
4. 7319111 - Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists (2008-01-15),
5. 7288538 - Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists (2007-10-30),
6. 7265122 - Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists (2007-09-04),
7. 6972296 - Carboxylic acid derivatives that inhibit the binding of integrins to their receptors (2005-12-06),
8. 6686382 - Sulfonamides and derivatives thereof that modulate the activity of endothelin (2004-02-03),
9. 6613804 - Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin (2003-09-02),
Encysive Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapies to treat cardiovascular and pulmonary diseases. Their innovative products aim to address significant unmet medical needs in these areas. With a commitment to advancing healthcare through research and development, Encysive Pharmaceuticals strives to improve the lives of patients worldwide.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

9 Patents

#762 in New York, NY

#1,901 in New York

#32,565 in US

New York, NY (US)
New York, NY, United States of America

Encysive Pharmaceuticals, Inc.

Forward Citations = 94

25 inventors:

goldMedal Chengde Wu (7 out of 31 patents)

silverMedal Wen Li (4 out of 43 patents)

bronzeMedal Robert V Market (4 out of 17 patents)

4.  Daxin Gao (4 out of 5 patents)

5.  George W Holland (4 out of 50 patents)

Please report any incorrect information to [email protected]
Loading…